Member Info for Chelsea11

AB - re your 8:16 response to me, I agree there are many considerations re the status of the trials.

However, I was simply correcting your 07:29 “no bloody trials running”. Your words.

Incorrect. There are 2 trials running. Regardless of their status and anyone’s personal view of that status.

AB - isn’t it a fact that 2x trials ARE running?

I suppose if you were short of toilet paper………..

Oh the irony!

Well, Never Say Die won The Derby in 1954 with an 18 year old Lester Piggott on his back.

At odds of 33/1.

So, yes Ruck!

Yes but we have got Lester Piggott riding it.

Good luck today everyone.

They sell COVID vaccines on the Deli at your local supermarket Johnny?

Distribution logistics by Sean Dyche truck. Sorted.

Good luck today folks.

AGM tomorrow then. I expect an accompanying statement on trading.

This is interesting in respect of COVIDITY. Remember that the candidates must live in Cape Town. Article is one week old.

https://www.npr.org/2022/02/01/1077300788/south-africa-covid-isolation-restrictions?t=1644306041460

I hope you find the link below of interest from both a Covidity and Moditope perspective. Some quite shocking numbers within.

https://www.euro.who.int/en/media-centre/sections/statements/2022/statement-cancer-services-disrupted-by-up-to-50-in-all-countries-reporting-a-deadly-impact-of-covid-19

Pretty sure it was Berm who voiced an opinion on the significance of the peptide issue (my description). Final hurdles to jump over, not sure how tall they are currently…….

The challenges associated with formulation of the citrullinated enolase peptide have now been successfully resolved and the Company expects to start clinical trials during H1 2022 with safety and immunological data due in H2 2022 and efficacy data being received in 2023. Like other companies within the sector, Scancell is finding that the set up and running of clinical trial sites in the UK is being impacted by staff shortages in the NHS caused by COVID-19, which the Company plans to mitigate by increasing the number of trial sites, widening the patient selection criteria and minimising hospital visits for enrolled patients.

Thanks Ciaskin.

If we could just get MODI-1 FPD news out there to compliment that kind of article…………

It surely cannot be far away.

Not sure Ruck. If you look at the Data Sources on the link I’ve provided below, you can see where those numbers are coming from.

Perhaps we should conclude that there are many vaccine candidates and we have one in trial, with a status update provided this week.

Let’s hope we stay firmly in the “race” and can show a terrific turn of foot in the coming weeks.

Oh. There was me thinking they’re both COVID Vaccine Trackers.

118 doesn’t match the link I posted below?

https://covid19.trackvaccines.org/

RR - my 20.22. No intent to insult anyone and apologies if it came across that way.

Whilst I concede that Hold Em or Fold Em might be a crude way of expressing it, the reality is that whether you’ve been here 1 day, 1 week, 1 year or 10 years, that is the investment choice we all have to make.

I’m holding btw :-)

Relax. Cadbury’s Caramel. What happened 3, 5 or 10 years ago with the SP, is clearly no longer relevant.

Inflection points coming inside 12 months imo. Hold em, or fold em.

Morning C7.

Let’s hope we end the week with the SP starting with a 2.

Don’t mean £2 quid. Not yet anyway :-)

https://www.marketwatch.com/story/scancell-says-scov2-vaccine-candidate-showed-strongest-response-to-omicron-271643614725